pyridoxal has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
Excerpt | Relevance | Reference |
---|---|---|
"Gut microbiota dysbiosis is intimately associated with development of non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)." | 1.91 | Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. ( Abdollahiyan, S; Asadzadeh Aghdaei, H; Farahanie, A; Gérard, P; Hatami, B; Keshavarz Azizi Raftar, S; Monnoye, M; Nabavi-Rad, A; Salarieh, N; Yadegar, A; Zali, MR, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abdollahiyan, S | 1 |
Nabavi-Rad, A | 1 |
Keshavarz Azizi Raftar, S | 1 |
Monnoye, M | 1 |
Salarieh, N | 1 |
Farahanie, A | 1 |
Asadzadeh Aghdaei, H | 1 |
Zali, MR | 1 |
Hatami, B | 1 |
Gérard, P | 1 |
Yadegar, A | 1 |
1 other study available for pyridoxal and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Topics: Cross-Sectional Studies; Dysbiosis; Gastrointestinal Microbiome; Humans; Iran; Liver; Non-alcoholic | 2023 |